Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-023935
Filing Date
2016-05-05
Accepted
2016-05-05 19:10:25
Documents
1
Period of Report
2016-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3045
  Complete submission text file 0001179110-16-023935.txt   4452
Mailing Address C/O PRUDENTIAL FINANCIAL INC 751 BROAD ST. 4TH FL. NEWARK NJ 07102
Business Address
MALKIEL BURTON G (Reporting) CIK: 0001184677 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 161625510

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations